Six Mineral Supplements Tested. One Rule Predicted Every Result.

You've seen the posts. Magnesium for sleep. Zinc for testosterone. Iron for energy. And somewhere underneath the confident advice, a nagging question: does any of this actually work?

The supplement industry pulls in roughly $50 billion per year in the US alone, and minerals are its fastest-growing segment. The marketing says "everyone needs them." The science says something more nuanced, more useful, and cheaper.

Zinc supplements correct testosterone in deficient men. Iron supplements rescue endurance in deficient female athletes. Magnesium helps older adults fall asleep faster. Each finding comes from a major evidence review. Each one holds up.

And the daily multivitamin that bundles all three minerals into one pill, tested across 19 meta-analyses and 5.5 million people, produces zero measurable benefit. Not small benefit. Not inconsistent benefit. Zero.

Both sides of this are true. Together, they should be impossible. The question isn't whether supplements work. It's which ones, for whom, and why the answer depends on a test most people have never taken.

This guide exists because that contradiction has an answer. One rule, buried across six evidence reviews, explains it all. Why single minerals help and multivitamins don't. Why the biggest study finds the clearest zero.

This is not a guide that tells you which supplements to buy. Six research teams studied six different minerals. They all landed on the same rule.

What went into this: six major evidence reviews covering vitamin D, zinc, magnesium (sleep and soreness, tracked separately), iron, and multivitamins. Sixteen supporting studies. More than five million people total. Every finding checked through our Skeptic Protocol.

The most-shared claim in supplement marketing is that ZMA boosts free testosterone by 33.5%. That number comes from one study, published in an unindexed journal, with 53% of participants dropping out before the trial ended. The co-author held the patent on ZMA, and later pled guilty in a federal steroid distribution case.

Two independent research teams replicated the experiment. Their combined result: zero effect.

One detail the supplement industry exploits: the original study measured free testosterone, which is more volatile and easier to show short-term changes in. No replication has confirmed that finding. The two clean attempts found nothing.

But zinc itself is not the fraud. The same 45-year evidence base that destroys the ZMA claim confirms a different finding. Thirty-eight studies consistently show that zinc deficiency crashes testosterone. Correct the deficiency, testosterone recovers. Supplement above normal levels, and nothing changes.

The pattern held across clinical trials, animal models, and subgroup analyses from adolescents to elderly men. One clinical trial found the effect was clearly deficiency-dependent: men with testosterone below 4.8 nmol/L showed significant improvement, while those already above that threshold saw nothing.

Zinc is a building block for testosterone synthesis. Below a certain threshold, the factory can't run. Above it, more raw material doesn't speed up production. The relationship is biological, not pharmaceutical. There is a floor, not a sliding scale.

How would you know if you're below that floor? A serum zinc blood test costs about the same as a month of ZMA. If you're below the threshold, plain zinc at $5–8 per month corrects the problem. If you're above it, nothing in a capsule will push testosterone higher. The test costs less than two months of the supplement it might replace.

One finding makes this personal for anyone who trains: athletes consistently eat more zinc than non-active people, yet carry less of it in their blood. Training depletes zinc faster than diet replaces it. The people least likely to worry about zinc status are the most likely to be deficient. And they're the ones spending the most on ZMA.

The same pattern appears with a different mineral. Hundreds of athletes took vitamin D supplements. Their blood levels climbed significantly. Their overall muscle strength didn't change across ten trials.

One muscle group responded: the quadriceps, which carry the highest concentration of vitamin D receptors on fast-twitch fibers. And that response only appeared in athletes who were deficient to begin with. Blood up. Muscles unchanged. Except the one tissue built to catch the signal.

Two minerals. Two independent research teams. Two completely different outcomes. Same rule: works below a floor, nothing above it.

Up to 60% of female athletes have low iron levels. Most of them have been told their blood work is normal. They're already losing up to 19% of their endurance, across 23 studies and nearly 700 athletes in 16 sports. The blood work was checking the wrong marker.

Iron has three stages of shortage, and this is where the problem hides. Standard blood tests check hemoglobin, which stays normal until Stage 3 — full anemia. But performance drops in Stage 1, when stored iron empties while hemoglobin hasn't budged.

By Stage 2, the enzymes that process oxygen slow down. The athlete feels heavier, recovers slower, can't finish intervals the way she used to, and has a lab report that says everything is fine.

This staging matters because it changes what "normal" means. A female distance runner with ferritin at 20 µg/L and hemoglobin at 12.5 g/dL will pass a standard blood panel. She's in Stage 1 or early Stage 2. And she's potentially leaving 10–19% of her endurance on the table without either she or her doctor knowing it.

Iron carries oxygen AND helps muscles turn it into energy. Low iron means less oxygen reaches working muscles AND less energy comes out of what arrives. A double hit that looks like overtraining, poor recovery, or bad programming. All three get blamed before anyone checks ferritin.

The practical fix, when ferritin confirms deficiency, is specific: at least 100mg of elemental iron per day improved endurance by roughly 20% across the evidence base. Below 100mg per day, no endurance benefit appeared in any study. That threshold matters because the dose makes or breaks the result. It also reveals a quiet fact about your multivitamin.

Your multivitamin contains 18mg. That is 18% of the effective dose. The daily pill that promises to "cover your bases" delivers less than a fifth of what the evidence says is necessary for the people who need it most.

The marker that catches iron deficiency early is ferritin, not hemoglobin. Hemoglobin is the last domino to fall. Ferritin is the first. By the time hemoglobin drops, performance has already been declining for weeks or months. One test, one number, one question your next blood panel should include.

Magnesium is the most recommended mineral on social media for sleep. It's also gaining traction for post-training soreness. The evidence for both is real. The evidence for both is also remarkably thin.

The sleep case: three small trials found that magnesium helped people fall asleep 17 minutes faster, a consistent and real reduction. Total sleep time did not improve. All three trials enrolled adults over 55. Zero young-adult data exists.

The evidence quality was rated Low to Very Low by the review's own standards. The NIH's magnesium fact sheet covers 64 references and four health conditions. Sleep is not among them, despite being the number-one consumer reason for buying magnesium.

Magnesium activates GABA receptors, the brain's slow-down signal. That explains why the evidence supports faster sleep onset but not longer sleep. Falling asleep is about calming the switch. Staying asleep is a different system entirely.

The soreness case: out of more than twelve hundred studies screened, four passed the quality bar. All four found magnesium reduced soreness. Total evidence base: 73 people. Every single one in the positive direction. An early signal, not a proven fix.

Same mineral, opposite evidence for cramps: a Cochrane review of 735 people found magnesium unlikely to help cramps. A completely different condition that shares nothing but the supplement aisle.

What both outcomes share: conditional on deficiency. About 48% of adults fall below recommended magnesium intake. If you're in that half, one evening capsule might address both outcomes. If you're not, the evidence gives you nothing to work with.

And the form debate all over the internet (glycinate vs. oxide vs. threonate) is backed by zero head-to-head trials. The cheapest forms (oxide, citrate) produced all the positive evidence.

The $300-per-year premium for branded sleep formulas buys marketing, not proof. Cheap forms have the evidence. Expensive forms have the Instagram posts.

Three minerals. Three research teams in different countries. Same finding: works below a floor, nothing above it.

Minerals have floors, not ceilings. Below the floor, the body can't run the process it needs — making testosterone, carrying oxygen, calming the brain for sleep. Above it, adding more doesn't speed anything up.

That pattern makes a testable prediction. If the rule is "fix what's broken, don't add what isn't," then bundling twenty-plus minerals at tiny doses — without testing what's actually low — should produce zero benefit.

It does.

Nineteen meta-analyses. 5.5 million participants. Zero benefit across mortality, heart disease, cancer, infections, and exercise performance in healthy adults. More than a hundred studies on mineral supplements in athletes specifically: zero performance benefit. The most-studied supplement question in history has a flatline answer.

The deficiency gate explains why. Every mineral in the bundle has real evidence behind it — but only at the right dose, for the right person. The iron that rescued endurance needed 100mg per day. The multivitamin delivers 18mg. Each ingredient built for no one, aimed at everyone.

Early studies that found a benefit vanished under controlled trials. People who take multivitamins also exercise more, eat better, and see doctors more often — the lifestyle caused the health, not the pill.

The only non-zero finding across all 19 reviews was harm. Multivitamins doubled the progression risk of age-related macular degeneration (2.08 times higher, across 13 trials and 85,321 people). "At worst, expensive urine" understates it. There may be a cost beyond money.

Twenty-plus nutrients at tiny doses without testing for what's actually low can't produce a result. The mechanism's absence IS the finding. Nothing happened because nothing could.

One more note for people who train: the ISSN position stand flags that antioxidant supplements may blunt training gains. The same molecules that mop up free radicals also mop up the stress signals muscles need to grow. The multivitamin might not only be doing nothing. For athletes, it might be doing less than nothing.